Benjamin

BioDrop Solutions is pioneering non-invasive neurological diagnostics through advanced tear-based microRNA profiling. Our innovative hydrogel contact lens technology captures and preserves tear fluid biomarkers, enabling early detection of gliomas and other neurodegenerative diseases with a simple, comfortable collection process. Headquartered in Riga, Latvia, we combine cutting-edge biomaterial engineering with AI-powered analytics to deliver high-sensitivity, sample-to-answer diagnostic solutions. By integrating next-generation molecular analysis with patient-friendly sampling, BioDrop empowers clinicians to diagnose life-threatening conditions earlier, improving treatment outcomes and survival rates. Our team comprises neuroscientists, biotech executives, and medical device innovators dedicated to transforming neurological diagnostics. We are currently advancing through clinical validation, scaling manufacturing partnerships, and preparing for regulatory approvals to bring this technology to market globally. Mission: To revolutionize neurological diagnostics through non-invasive, accessible, and accurate biomarker detection. 📧 Contact: contact@biodropsolutions.com